Search results
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 17 hours agoTrulicity had $1.46 billion in first-quarter sales, down 26% and below the $1.63 billion Street...
Can Weight Loss Drugs Like Wegovy and Zepbound Help You Live a Longer Life?
Healthline via AOL· 3 days agoLearn more about how to get GLP-1 medications...multiple different types of medications have made...
Colorectal cancer: How Metformin could help slow cancer cell growth
Medical News Today· 7 days agoUsing several different techniques to analyze the drug’s effects on the cells’ RNA, they found that...
Doctors Test the Limits of What Obesity Drugs Can Fix
New York Times· 3 days ago“Obesity first” doctors say they start with one pill, to treat obesity, and often find other chronic...
AI Enhances Readability of Cancer Information for Patients
Medscape· 4 days agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
10 Reasons to Buy Eli Lilly Stock Now
247wallst.com· 7 days agoThe pharmaceutical sector is one that has gone from decades of heavy investment, high growth, and consolidation to a maturing space with a few key...
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com
Investing.com· 7 days agoStocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
GLP-1 Drugs Before Bariatric Surgery Can Help People With Extreme Obesity
Healthline via AOL· 4 days agoNew research has found that for people with extreme obesity taking GLP-1 drugs like Ozempic or...
Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for...
KPVI· 7 days agoArthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels ...